The Development of a Floating Drug-Delivery System for Metronidazole - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

The Development of a Floating Drug-Delivery System for Metronidazole
The authors developed a metronidazole-based floating drug-delivery system to investigate the effect of rate-controlling polymers on release pattern and duration of buoyancy in matrix tablets.

Pharmaceutical Technology
pp. 41-44

Results and discussion

Table II: Physical characteristics of the metronidazole tablet.
The weight, diameter, and thickness ranges are shown in Table II. Tablet hardness increased in direct proportion to the amount of pressure applied and in indirect proportion to the concentration of polymers. Hardness also varied according to the type of polymers included. The percent friability was less than 0.5%. The data obtained are shown in Table II.

Table III: Flow properties of granules.
The bulk density of the granules was between 0.322 and 0.788 g/cm3 , indicating their good packing capacity. The tapped density of the granules was between 0.375 and 0.866 g/cm3 , showing good flow characteristics. The Carr's index, Hausner's ratio, and angle of repose of the granules were within range, thus indicating good flowability. Results are shown in Table III.

The 80-mg tablet formulations containing Methocel K15M CR showed significant water penetration (i.e., 17%) that enabled the tablet to dissolve, whereas formulations containing HPC showed only 1–4% water penetration. The metronidazole formulation containing Methocel K15M CR and Carbomer 934P had a floating lag time of less than 300 s. Formulations using HPC had no buoyancy after 8 h. Formulations containing Methocel K15M CR had floating time of 4 h, and Carbomer 934P had a floating time of 8 h (see Table I).

Tablets' floating capacity depends on the density of the system, the quantity of the gas-generating agents (i.e., NaHCO3 and citric acid), and the concentration of polymers. Table I shows the floating lag time of the tablets. The tablets formulated with Methocel K15M CR and Carbomer 934P became buoyant after 5 min of contact with the dissolution medium, but the HPC-containing tablets did not show any buoyancy after 8 h.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here